The how (and why) of disease registers

Early Human Development

Volumn 86, Issue 11, 2010, Pages 723-728

  Mehta, Anil ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Audit; Database; Outcome; Rare disease; Register design; Screening

Indexed keywords

ARTICLE; CYSTIC FIBROSIS; DISEASE REGISTRY; EUROPE; HUMAN; INFORMATION PROCESSING; MEDICAL AUDIT; MEDICAL SPECIALIST; NEWBORN SCREENING; OUTCOME ASSESSMENT; PATIENT REFERRAL; STANDARD; UNITED KINGDOM;

CONFIDENTIALITY; CYSTIC FIBROSIS; DOCUMENTATION; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MASS SCREENING; REGISTRIES; SCOTLAND; TREATMENT OUTCOME;

EID: 78049259974     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.08.006     Document Type: Article

References (12)

1. McCormick J., Mehta G., Olesen H.V., Viviani L., Macek M., Mehta A. Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet 2010, 375(9719):1007-1013.
2. Dodge J.A., Lewis P.A., Stanton M., Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007, 29(3):522-526.
3. McCormick J., Green M.W., Mehta G., Culross F., Mehta A. Demographics of the UK cystic fibrosis population: implications for neonatal screening. Eur J Hum Genet 2002, 10(10):583-590.
4. Mehta G., Sims E.J., Culross F., McCormick J.D., Mehta A. Potential benefits of the UK Cystic Fibrosis Database. J R Soc Med 2004, 97(Suppl 44):60-71.
5. Black N. High-quality clinical databases: breaking down barriers. Lancet 1999, 353(9160):1205-1206.
6. Sims E.J., Green M.W., Mehta A. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. Diab Care 2005, 28(7):1581-1587.
7. Lai H.J., Cheng Y., Cho H., Kosorok M.R., Farrell P.M. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol 2004, 159(6):537-546.
8. Schechter M.S., Margolis P.A. Relationship between socioeconomic status and disease severity in cystic fibrosis. J Pediatr 1998, 132(2):260-264.
9. Schechter M.S., McColley S.A., Silva S., Haselkorn T., Konstan M.W., Wagener J.S. Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis. J Pediatr 2009, 155(5):634-639.
10. Farrell P.M. The meaning of "early" diagnosis in a new era of cystic fibrosis care. Pediatrics 2007, 119(1):156-157.
11. Sims E.J., Mugford M., Clark A., Aitken D., McCormick J., Mehta G., et al. Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study. Lancet 2007, 369(9568):1187-1195.
12. McCormick J., Sims E.J., Green M.W., Mehta G., Culross F., Mehta A. Comparative analysis of Cystic Fibrosis Registry data from the UK with USA, France and Australasia. J Cyst Fibros 2005, 4(2):115-122.